Sex Differences in Gene Expression in Human Adipose Tissue
August 17, 2009 updated by: University of California, San Diego
This project was created to assess sex differences in adipose tissue gene expression in different locations in the body. The primary objectives are to understand:
- The mechanisms of differential body fat distribution in men and women
- How body fat distribution is affected by reproductive hormones
- The mechanisms linking fat distribution to health risks such as diabetes
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
10
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
La Jolla, California, United States, 91963-0063
- UCSD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 35 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
General Population
Description
Inclusion Criteria:
- Caucasian men and women 20-35 years of age
- Lean (BMI less than 25)
- Obese (BMI 30-35)
Exclusion Criteria:
- Hormonal birth control
- Pregnancy
- Smokers
- History of diabetes, kidney, liver or thyroid disease
- History of cancer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
1
Five caucasian women
|
Adipose tissue will be sampled from the abdomen and buttock
Blood will be sampled from an IV line
Single image at the level of the liver
Whole body scan
|
|
2
Five caucasian men
|
Adipose tissue will be sampled from the abdomen and buttock
Blood will be sampled from an IV line
Single image at the level of the liver
Whole body scan
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Adipose and blood sampling
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
CT scan and DEXA scan
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Jeffrey Chang, M.D., UCSD
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2008
Primary Completion (Actual)
August 1, 2009
Study Completion (Actual)
August 1, 2009
Study Registration Dates
First Submitted
May 12, 2008
First Submitted That Met QC Criteria
May 12, 2008
First Posted (Estimate)
May 14, 2008
Study Record Updates
Last Update Posted (Estimate)
August 18, 2009
Last Update Submitted That Met QC Criteria
August 17, 2009
Last Verified
August 1, 2009
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 070668
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.